|
|
(One intermediate revision not shown.) |
Line 3: |
Line 3: |
| <StructureSection load='4p83' size='340' side='right'caption='[[4p83]], [[Resolution|resolution]] 2.50Å' scene=''> | | <StructureSection load='4p83' size='340' side='right'caption='[[4p83]], [[Resolution|resolution]] 2.50Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[4p83]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Synthetic_construct_sequences Synthetic construct sequences]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P83 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P83 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4p83]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P83 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4P83 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=U5P:URIDINE-5-MONOPHOSPHATE'>U5P</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4p80|4p80]], [[4p81|4p81]], [[4p82|4p82]], [[4p84|4p84]], [[4p86|4p86]]</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=U5P:URIDINE-5-MONOPHOSPHATE'>U5P</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p83 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p83 OCA], [http://pdbe.org/4p83 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4p83 RCSB], [http://www.ebi.ac.uk/pdbsum/4p83 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4p83 ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4p83 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p83 OCA], [https://pdbe.org/4p83 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4p83 RCSB], [https://www.ebi.ac.uk/pdbsum/4p83 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4p83 ProSAT]</span></td></tr> |
| </table> | | </table> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
Line 22: |
Line 22: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Synthetic construct sequences]] | + | [[Category: Synthetic construct]] |
- | [[Category: Clarke, J]] | + | [[Category: Clarke J]] |
- | [[Category: Kondo, Y]] | + | [[Category: Kondo Y]] |
- | [[Category: McLaughlin, S]] | + | [[Category: McLaughlin S]] |
- | [[Category: Perica, T]] | + | [[Category: Perica T]] |
- | [[Category: Reuter, N]] | + | [[Category: Reuter N]] |
- | [[Category: Steward, A]] | + | [[Category: Steward A]] |
- | [[Category: Teichmann, S A]] | + | [[Category: Teichmann SA]] |
- | [[Category: Tiwari, S]] | + | [[Category: Tiwari S]] |
- | [[Category: Reconstructed amino acid sequence]]
| + | |
- | [[Category: Rna binding protein]]
| + | |
- | [[Category: Transcription]]
| + | |
| Structural highlights
Publication Abstract from PubMed
Evolution and design of protein complexes are almost always viewed through the lens of amino acid mutations at protein interfaces. We showed previously that residues not involved in the physical interaction between proteins make important contributions to oligomerization by acting indirectly or allosterically. In this work, we sought to investigate the mechanism by which allosteric mutations act, using the example of the PyrR family of pyrimidine operon attenuators. In this family, a perfectly sequence-conserved helix that forms a tetrameric interface is exposed as solvent-accessible surface in dimeric orthologs. This means that mutations must be acting from a distance to destabilize the interface. We identified 11 key mutations controlling oligomeric state, all distant from the interfaces and outside ligand-binding pockets. Finally, we show that the key mutations introduce conformational changes equivalent to the conformational shift between the free versus nucleotide-bound conformations of the proteins.
Evolution of oligomeric state through allosteric pathways that mimic ligand binding.,Perica T, Kondo Y, Tiwari SP, McLaughlin SH, Kemplen KR, Zhang X, Steward A, Reuter N, Clarke J, Teichmann SA Science. 2014 Dec 19;346(6216):1254346. doi: 10.1126/science.1254346. PMID:25525255[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Perica T, Kondo Y, Tiwari SP, McLaughlin SH, Kemplen KR, Zhang X, Steward A, Reuter N, Clarke J, Teichmann SA. Evolution of oligomeric state through allosteric pathways that mimic ligand binding. Science. 2014 Dec 19;346(6216):1254346. doi: 10.1126/science.1254346. PMID:25525255 doi:http://dx.doi.org/10.1126/science.1254346
|